Evidence map›Paper›PMID 36128327›Full record

ArticleOncotarget2022

Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma.

Edwin Cevallos Barrera, Edson Zangiacomi Martinez, Mariangela Ottoboni Brunaldi, Eduardo Antonio Donadi, Ajith Kumar Sankarankutty, Rafael Kemp, José Sebastiao Dos Santos

Abstract read
In one paragraph

Article in Oncotarget, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Edwin Cevallos BarreraUniversidad Central del Ecuador, Ciencias Médicas, Carrera de Medicina, Hospital de Especialidades de Fuerzas Armadas HE-1, Quito, Ecuador.
Edson Zangiacomi MartinezDepartment of Social Medicine, Ribeirao Preto Medical School, University of São Paulo, São Paulo, Brazil.
Mariangela Ottoboni BrunaldiDepartment of Pathology, Ribeirao Preto Medical School, University of São Paulo, São Paulo, Brazil.
Eduardo Antonio DonadiDepartment of Internal Medicine, Ribeirao Preto Medical School, University of São Paulo, São Paulo, Brazil.
Ajith Kumar SankarankuttyDepartment of Surgery and Anatomy, Ribeirao Preto Medical School, University of São Paulo, São Paulo, Brazil.
Rafael KempDepartment of Surgery and Anatomy, Ribeirao Preto Medical School, University of São Paulo, São Paulo, Brazil.
José Sebastiao Dos SantosDepartment of Surgery and Anatomy, Ribeirao Preto Medical School, University of São Paulo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the incidence of gastric adenocarcinoma (GA) is high in populations living at high altitudes, we evaluated the influence of altitude on the expression of HIF-1 and survival of Ecuadorian GA patients.

method155 GA cases were studied: 56 from coastal (GAC) and 99 from mountainous regions (GAM), and 74 non-GA controls (25 coast and 49 mountain). The expression of HIF-1/HER2 was analyzed by immunohistochemistry. Analyses were performed using Fisher's exact and Breslow-Day tests for homogeneity and Kaplan-Meier curves and restricted median survival time ΔRMST.

resultsHIF-1 was overexpressed in normal/inflamed gastric mucosa, especially in mountainous non-GA patients (

conclusionDespite the limitations of this retrospective study, GA patients in the coastal region and those who expressed HIF-1 exhibited a better prognosis, but this factor was associated with better survival only in the mountain region.

Indexed as

AdenocarcinomaAltitudeStomach NeoplasmsEcuadorHumansHypoxia-Inducible Factor 1Hypoxia-Inducible Factor 1, alpha SubunitPrognosisRetrospective StudiesHypoxia-Inducible Factor 1Hypoxia-Inducible Factor 1, alpha Subunitgastric adenocarcinomaHER2hypoxia-induced factorsurvival ratetumor markers

Identifiers

PMID36128327
PMCPMC9477223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.